Novitium Pharma LLC recalls Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Dr…
- Recall date
- March 25, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0443-2024
- FDA classification
- Class III
- Brand / firm
- Novitium Pharma LLC
- Sold / distributed
- U.S. Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10
Get recall alerts
Free email alert whenever Novitium Pharma LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Novitium Pharma LLC